Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Aug;90 Suppl 5(Suppl 5):v34-6.
doi: 10.1136/hrt.2003.019133.

Myocardial perfusion scintigraphy and cost effectiveness of diagnosis and management of coronary heart disease

S R Underwood  1 , L J Shaw, C Anagnostopoulos, M Cerqueira, P J Ell, J Flint, M Harbinson, A Kelion, A Al Mohammad, E M Prvulovich
Affiliations
Review

Myocardial perfusion scintigraphy and cost effectiveness of diagnosis and management of coronary heart disease

S R Underwood et al. Heart. 2004 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pre-and post-test likelihood of CHD calculated using Bayesian principles for the exercise ECG and MPS, using sensitivities of 68% and 92%, respectively, and specificities of 77% and 88%, respectively. The curved lines from top to bottom represent MPS+, ECG+, ECG– and MPS–.
Figure 2
Figure 2
Two year costs of diagnosis (dark grey) and management (light grey) in patients without CHD but presenting with stable chest pain syndromes, according to strategy of investigation and type of hospital. The strategies of investigation are: (1) exECG-angio; (2) exECG-MPS-angio; (3) MPS-angio; (4) angio. Angio, angiography; exECG, exercise ECG; MPS, myocardial perfusion scintigraphy. MPS = regular user of MPS; non-MPS = occasional user of MPS.2
Figure 3
Figure 3
Two and a half year costs of diagnosis (dark grey) and management (light grey) in 11 372 patients presenting with stable chest pain syndromes who underwent initial angiography or MPS with selective angiography, according to low, intermediate or high pre-test likelihood of CHD.12
See this image and copyright information in PMC

References

    1. Heart. 2001 Feb;85(2):149-52 - PubMed
    1. J Am Coll Cardiol. 1999 May;33(6):1756-824 - PubMed
    1. J Nucl Cardiol. 2002 Sep-Oct;9(5):515-22 - PubMed
    1. J Am Coll Cardiol. 2003 Jun 4;41(11):1906-17 - PubMed
    1. J Am Coll Cardiol. 1984 Aug;4(2):278-89 - PubMed

MeSH terms